Tomoyuki Takahashi

发表

Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment

M. Arai, G. Takemura, S. Minatoguchi, 2004, Circulation.

Alterations of Gene Expression and Glutamate Clearance in Astrocytes Derived from an MeCP2-Null Mouse Model of Rett Syndrome

T. Matsuishi, Y. Okabe, Tomoyuki Takahashi, 2012, PloS one.

Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting.

H. Ushikoshi, G. Takemura, T. Kunisada, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2.

H. Ushikoshi, H. Fujiwara, Tomoyuki Takahashi, 2004, Circulation journal : official journal of the Japanese Circulation Society.

Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.

G. Takemura, S. Minatoguchi, H. Fujiwara, 2009, American journal of physiology. Heart and circulatory physiology.

Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure Signal Modulates β Postinfarction Gene Therapy Against Transforming Growth

G. Takemura, S. Minatoguchi, H. Fujiwara, 2005 .

Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure

G. Takemura, S. Minatoguchi, H. Fujiwara, 2005 .

Critical Roles for the Fas/Fas Ligand System in Postinfarction Ventricular Remodeling and Heart Failure

G. Takemura, S. Minatoguchi, H. Fujiwara, 2004, Circulation research.

Postinfarction Treatment With an Adenoviral Vector Expressing Hepatocyte Growth Factor Relieves Chronic Left Ventricular Remodeling and Dysfunction in Mice

H. Mizuguchi, G. Takemura, S. Minatoguchi, 2003, Circulation.

Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.

T. Matsuishi, H. Fujiwara, Tomoyuki Takahashi, 2006, International journal of oncology.

Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes

H. Ushikoshi, G. Takemura, S. Minatoguchi, 2005, Laboratory Investigation.

Molecular mechanisms of non-apoptosis by Fas stimulation alone versus apoptosis with an additional actinomycin D in cultured cardiomyocytes.

T. Aoyama, G. Takemura, S. Minatoguchi, 2002, Cardiovascular research.

Intravenous Administration of Endothelial Colony‐Forming Cells Overexpressing Integrin β1 Augments Angiogenesis in Ischemic Legs

I. Kawamura, H. Ushikoshi, M. Kawasaki, 2016, Stem cells translational medicine.

In vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF.

H. Ushikoshi, H. Fujiwara, N. C. Khai, 2006, Journal of hepatology.

Hepatocyte Growth Factor Gene Therapy Slows Down the Progression of Diabetic Nephropathy in db/db Mice

G. Takemura, H. Fujiwara, Tomoyuki Takahashi, 2003, Nephron Physiology.

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF.

M. Arai, G. Takemura, S. Minatoguchi, 2006, Cardiovascular research.

Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.

H. Ushikoshi, G. Takemura, S. Minatoguchi, 2008, American journal of physiology. Heart and circulatory physiology.

In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions.

M. Arai, S. Yasuda, H. Ushikoshi, 2007, Journal of cardiac failure.

Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis.

K. Nishigaki, G. Takemura, S. Minatoguchi, 2010, The American journal of pathology.

Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.

G. Takemura, S. Minatoguchi, H. Fujiwara, 2004, Circulation.

Disturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmias

T. Matsuishi, M. Takano, G. Takemura, 2015, Scientific Reports.

Rett syndrome: The state of clinical and basic research, and future perspectives

T. Matsuishi, Tomoyuki Takahashi, Y. Yamashita, 2011, Brain and Development.

Cyclophosphamide improves the function of post-infarct hearts by reducing old infarct area and accelerating the mobilization of CD34+ cells.

M. Arai, H. Ushikoshi, G. Takemura, 2005, Circulation journal : official journal of the Japanese Circulation Society.

APPLICATION OF AN ADENOVIRAL VECTOR ENCODING SOLUBLE TRANSFORMING GROWTH FACTOR‐β TYPE II RECEPTOR TO THE TREATMENT OF DIABETIC NEPHROPATHY IN MICE

G. Takemura, S. Minatoguchi, H. Fujiwara, 2008, Clinical and experimental pharmacology & physiology.

588. Hepatic HB-EGF (Heparin-Binding EGF-Like Growth Factor) Gene Therapy for Fulminant Hepatic Failure in Mice: More Potent Protective and Mitogenic Effects for Hepatocytes Than HGF (Hepatocyte Growth Factor)

N. C. Khai, Tomoyuki Takahashi, K. Kosai, 2006 .

Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: A system for studying Rett syndrome

H. Higashi, T. Matsuishi, Y. Okabe, 2010, Brain Research.

Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma.

Toshikazu Nakamura, H. Ushikoshi, H. Fujiwara, 2005, International journal of oncology.

Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice

H. Fujiwara, N. C. Khai, Tomoyuki Takahashi, 2014, International journal of molecular medicine.

Circulating Myeloid Dendritic Cells is Decreased in the Acute Phase of Kawasaki Disease

T. Matsuishi, T. Imaizumi, K. Suda, 2013 .

Perampanel markedly improved clinical seizures in a patient with a Rett‐like phenotype and 960‐kb deletion on chromosome 9q34.11 including the STXBP1

T. Matsuishi, N. Matsumoto, Tomoyuki Takahashi, 2022, Clinical case reports.

Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine

K. Mitsui, Tomoyuki Takahashi, K. Kosai, 2017, Molecular therapy. Methods & clinical development.

Meaningful word acquisition is associated with walking ability over 10 years in Rett syndrome

T. Matsuishi, Tomoko Saikusa, S. Nabatame, 2020, Brain and Development.

Molecular Genetic and Bile Acid Profiles in Two Japanese Patients With 3β-Hydroxy-Δ5-C27-Steroid Dehydrogenase/Isomerase Deficiency

T. Matsuishi, H. Nittono, Tomoyuki Takahashi, 2010, Pediatric Research.

A Definitive Role of RhoC in Metastasis of Orthotopic Lung Cancer in Mice

H. Fujiwara, Tomoyuki Takahashi, K. Kosai, 2004, Clinical Cancer Research.

Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.

I. Kawamura, G. Takemura, S. Minatoguchi, 2009, American journal of physiology. Heart and circulatory physiology.

Pathogenesis of Lethal Aspiration Pneumonia in Mecp2-null Mouse Model for Rett Syndrome

T. Matsuishi, T. Taniwaki, M. Okamoto, 2017, Scientific Reports.

Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9‐based Rett syndrome model mouse

S. Honma, K. Yagita, T. Matsuishi, 2015, Genes to cells : devoted to molecular & cellular mechanisms.

Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.

T. Matsuishi, H. Nittono, A. Tanaka, 2012, Clinica chimica acta; international journal of clinical chemistry.

Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment

K. Ihara, T. Matsuishi, H. Nittono, 2013, Journal of Inherited Metabolic Disease.

Moving towards a novel therapeutic strategy for hyperammonemia that targets glutamine metabolism

H. Nagashima, H. Matsunari, Tomoyuki Takahashi, 2022, Journal of inherited metabolic disease.

Increased plasma type B natriuretic peptide in the acute phase of Kawasaki disease

T. Matsuishi, K. Suda, Tomoyuki Takahashi, 2011, Pediatrics international : official journal of the Japan Pediatric Society.

Molecular genetic and bile acid profiles in two Japanese patients with 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency.

T. Matsuishi, H. Nittono, Tomoyuki Takahashi, 2010, Pediatric research.